Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

71 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Platelet gel for treatment of mucocutaneous lesions related to graft-versus-host disease after allogeneic hematopoietic stem cell transplant.
Picardi A, Lanti A, Cudillo L, Cerretti R, Dentamaro T, De Angelis G, Ferraro A, Di Veroli A, Adorno G, Arcese W; Rome Transplant Network. Picardi A, et al. Among authors: di veroli a. Transfusion. 2010 Feb;50(2):501-6. doi: 10.1111/j.1537-2995.2009.02439.x. Epub 2009 Oct 9. Transfusion. 2010. PMID: 19821947 Clinical Trial.
Minimal residual disease as biomarker for optimal biologic dosing of ARA-C in patients with acute myeloid leukemia.
Maurillo L, Buccisano F, Piciocchi A, Del Principe MI, Sarlo C, Di Veroli A, Panetta P, Irno-Consalvo M, Nasso D, Ditto C, Refrigeri M, De Angelis G, Cerretti R, Arcese W, Sconocchia G, Lo-Coco F, Amadori S, Venditti A. Maurillo L, et al. Among authors: di veroli a. Am J Hematol. 2015 Feb;90(2):125-31. doi: 10.1002/ajh.23893. Epub 2014 Nov 24. Am J Hematol. 2015. PMID: 25377359 Free article. Clinical Trial.
Pre-transplant persistence of minimal residual disease does not contraindicate allogeneic stem cell transplantation for adult patients with acute myeloid leukemia.
Buccisano F, Maurillo L, Piciocchi A, Del Principe MI, Picardi A, Cerretti R, Cudillo L, De Angelis G, Sarlo C, Cefalo M, Ditto C, Di Veroli A, Mariotti B, Nasso D, De Bellis E, Del Poeta G, Voso MT, Sconocchia G, Lo Coco F, Arcese W, Amadori S, Venditti A. Buccisano F, et al. Among authors: di veroli a. Bone Marrow Transplant. 2017 Mar;52(3):473-475. doi: 10.1038/bmt.2016.308. Epub 2016 Dec 12. Bone Marrow Transplant. 2017. PMID: 27941782 No abstract available.
Minimal residual disease as a biomarker for outcome prediction and therapy optimization in acute myeloid leukemia.
Buccisano F, Maurillo L, Del Principe MI, Di Veroli A, De Bellis E, Biagi A, Zizzari A, Rossi V, Rapisarda V, Amadori S, Voso MT, Lo-Coco F, Arcese W, Venditti A. Buccisano F, et al. Among authors: di veroli a. Expert Rev Hematol. 2018 Apr;11(4):307-313. doi: 10.1080/17474086.2018.1447378. Epub 2018 Mar 7. Expert Rev Hematol. 2018. PMID: 29495904 Review.
Quality-of-life monitoring during hematopoietic stem cell transplantation: observations and a suggestion from the rome transplant network quality of life working party.
Tendas A, Pignatelli AC, Sollazzo F, Veggia B, Conte E, D'Apolito A, Di Veroli A, Molinari V, Mauroni M, Annibali O, Pilozzi V, Cacciaraichi S, Viggiani C, Niscola P, de Fabritiis P, Arcese W; Rome Transplant Network. Tendas A, et al. Among authors: di veroli a. J Pain Symptom Manage. 2013 Apr;45(4):e2-3. doi: 10.1016/j.jpainsymman.2012.12.007. Epub 2013 Mar 15. J Pain Symptom Manage. 2013. PMID: 23499456 Free article. No abstract available.
Minimal Residual Disease in Acute Myeloid Leukemia of Adults: Determination, Prognostic Impact and Clinical Applications.
Del Principe MI, Buccisano F, Maurillo L, Sconocchia G, Cefalo M, Consalvo MI, Sarlo C, Conti C, De Santis G, De Bellis E, Di Veroli A, Palomba P, Attrotto C, Zizzari A, Paterno G, Voso MT, Del Poeta G, Lo-Coco F, Arcese W, Amadori S, Venditti A. Del Principe MI, et al. Among authors: di veroli a. Mediterr J Hematol Infect Dis. 2016 Oct 20;8(1):e2016052. doi: 10.4084/MJHID.2016.052. eCollection 2016. Mediterr J Hematol Infect Dis. 2016. PMID: 27872732 Free PMC article. Review.
Treatment of Low-Blast Count AML using Hypomethylating Agents.
De Bellis E, Fianchi L, Buccisano F, Criscuolo M, Maurillo L, Cicconi L, Brescini M, Del Principe MI, Di Veroli A, Venditti A, Amadori S, Arcese W, Lo-Coco F, Voso MT. De Bellis E, et al. Among authors: di veroli a. Mediterr J Hematol Infect Dis. 2017 Jul 1;9(1):e2017045. doi: 10.4084/MJHID.2017.045. eCollection 2017. Mediterr J Hematol Infect Dis. 2017. PMID: 28698788 Free PMC article. Review.
71 results